Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance

DENVER (Map) - DENVER, April 9, 2008 /PRNewswire-FirstCall/--- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) (Wyndgate) division has formed a strategic marketing alliance with Cerner Corporation (Cerner) (Nasdaq: CERN), a leading provider of healthcare information technology (HIT) solutions. Cerner will market Wyndgate's comprehensive blood management software modules in conjunction with Cerner's universally known Millennium Suite laboratory information system (LIS). Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

"We are pleased that Cerner Corporation has selected Wyndgate blood management systems to complement its Millennium Suite," said Thomas F. Marcinek, President and COO of Global Med Technologies. "This strategic alliance will offer healthcare organizations feature-rich blood management solutions which will interface with Cerner's laboratory information systems, promoting increased efficiencies in blood banks, as well as supporting patient safety. The Cerner-Wyndgate affiliation further strengthens Wyndgate's position in the domestic and international blood management marketplace. Today Wyndgate's products and services manage, annually, more than eight million blood components, representing over 27% of the U.S. blood supply."

About Cerner Corporation

Cerner is a major U.S. supplier of healthcare information technology solutions that optimize clinical and financial outcomes. Around the world, healthcare organizations ranging from single-doctor practices to entire countries turn to Cerner for its powerful and intuitive solutions. Cerner offers clients a dedicated focus on healthcare, an end-to-end solution and service portfolio, and proven market strengths. Cerner Millennium is a healthcare information technology computing platform helping health professionals elevate safety, quality and efficiency.

About Global Med Technologies, Inc.

Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada, Africa, and the Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking from donor collection to patient transfusion through its Donor Doc(TM) interactive donor health history questionnaire, ElDorado Donor(TM) and SafeTrace(R) donor management systems, to its SafeTrace Tx(R) advanced transfusion management system. Global Med's PeopleMed(R), Inc. subsidiary provides custom software validation, consulting and compliance solutions to hospitals and blood centers. PeopleMed's in-depth knowledge of Wyndgate's products and the blood banking industry results in cost-effective validation services, which leads to more efficient software implementations and upgrades for our customers.

For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com, http://www.peoplemed.com and http://www.wyndgate.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.